Heilmann, Cory R
Eli Lilly (United States)
2 papers on CoChat
Most cited papers
- Verified
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): A randomised, open-label study
Buse, J. B., Nauck, M., Forst, T., Sheu, W. H.-H., Shenouda, S. K., Heilmann, C. R., Hoogwerf, B. J., Gao, A., Boardman, M. K., Fineman, M., et al. (2013) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 565
- Verified · note
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes: A Randomized, Controlled Trial
Buse, J. B., Bergenstal, R. M., Glass, L. C., Heilmann, C. R., Lewis, M. S., Kwan, A. Y. M., Hoogwerf, B. J., & Rosenstock, J. (2011) · Annals of Internal Medicine
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 506
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free